M.D. - University of Washington School of Medicine, Seattle, WA (1999)
M.S. - University of Virginia, Charlottesville, VA, Master of Science in Health Evaluation Sciences (2003-2004)
M.D. - University of Washington School of Medicine, Seattle, WA (1999)
M.S. - University of Virginia, Charlottesville, VA, Master of Science in Health Evaluation Sciences (2003-2004)
Residency - University of Washington Medical Center, Seattle, WA (2003)
Fellowship - Gynecologic Oncology, University of Virginia Medical Center, Charlottesville, VA (2006)
Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah C, Peters WA III. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging. Am J Obstet Gynecol (2008)198(6):679.el-9.
Bland AE, Everett EN, Pastore LM, Andersen WA, Taylor PT Jr. Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer 2008 Jul-Aug;18(4):629-36. Epub 2007 Nov 6.
Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, and Goff B. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2006 Jan 11;[Epub ahead of print]
Rice LW, Stone RL, Xu M, Galgano M, Stoler MH, Everett EN and Jazaeri AA. Biological targets for therapeutic intervention in endometroid endometrial adenocarcinoma and malignant mixed mullerian tumors. Am J Obstet Gynecol (2006)194,1119-28.
Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA and Taylor PT Jr. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. Am J Obstet Gynecol (2006)195, 568-76.